These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12932606)

  • 1. Sparing a little may save a lot: lessons from the Studies of Left Ventricular Dysfunction (SOLVD).
    Hernandez AF; O'Connor CM
    J Am Coll Cardiol; 2003 Aug; 42(4):709-11. PubMed ID: 12932606
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG; Schencking M; Scheer C; Rupp H
    Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharma-clinics. How I treat...symptomatic heart failure].
    Kulbertus H
    Rev Med Liege; 1999 Jul; 54(7):625-8. PubMed ID: 10495687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure, ventricular remodelling and the renin-angiotensin system: insights from recently completed clinical trials.
    Young JB
    Eur Heart J; 1993 Jul; 14 Suppl C():14-7. PubMed ID: 8365422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction.
    Pitt B
    Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical factors affecting serum potassium concentration in cardio-renal decompensation syndrome.
    Ueno H; Yoshimura M; Nakayama M; Yamamuro M; Nishijima T; Kusuhara K; Nagayoshi Y; Kojima S; Kaikita K; Sumida H; Sugiyama S; Ogawa H
    Int J Cardiol; 2010 Jan; 138(2):174-81. PubMed ID: 18804879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure and chronic kidney disease: should we use spironolactone?
    Agrawal S; Agrawal N; Garg J; Mohandas R; Gupta T; Segal M
    Am J Med Sci; 2015 Aug; 350(2):147-51. PubMed ID: 26086152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.
    Nicholls MG; Espiner EA; Hughes H; Rogers T
    Br Heart J; 1976 Oct; 38(10):1025-30. PubMed ID: 973876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Classic treatment of chronic heart insufficiency. What if new?].
    Aumont MC; Agnola D; Juliard JM; Karrillon G
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):599-602. PubMed ID: 7487308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
    Haller C
    Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heart failure due to diastolic dysfunction: the treatment principles].
    Pinamonti B; di Lenarda A; Sinagra G
    Ital Heart J Suppl; 2000 Apr; 1(4):469-80. PubMed ID: 10832133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract]   [Full Text] [Related]  

  • 14. Spironolactone in heart failure--a revived role for an old drug.
    Bradley C
    Intensive Crit Care Nurs; 2000 Dec; 16(6):403-4. PubMed ID: 11091472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone in chronic hemodialysis patients improves cardiac function.
    Taheri S; Mortazavi M; Shahidi S; Pourmoghadas A; Garakyaraghi M; Seirafian S; Eshaghian A; Ghassami M
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):392-7. PubMed ID: 19414940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiloride. A potassium-sparing natriuretic agent.
    Bull MB; Laragh JH
    Circulation; 1968 Jan; 37(1):45-53. PubMed ID: 5634728
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldosterone receptor antagonists for hypertension: what do they offer?
    Liew D; Krum H
    Drugs; 2003; 63(19):1963-72. PubMed ID: 12962513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone and antialdosterone therapy in congestive heart failure.
    Weber KT; Villarreal D
    Am J Cardiol; 1993 Jan; 71(3):3A-11A. PubMed ID: 8422002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New hope from a 40-year-old drug: deaths from heart failure cut by 30 percent.
    Comarow A
    US News World Rep; 1999 Aug; 127(5):69. PubMed ID: 10539698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.